Orchid Pharma Limited

NSE:ORCHPHARMA.NS

1479.85 (INR) • At close September 16, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22017 Q22015 Q12013 Q22012 Q42012 Q22011 Q4
Omzet 2,444.0612,171.0212,205.911,987.5531,829.1982,099.0081,597.6031,652.4961,309.8771,781.3231,613.7651,277.357923.1291,195.5971,027.841,085.5311,191.6361,115.2261,294.6331,316.3461,354.1991,424.7982,093.4152,563.3293,772.52,681.5673,305.4814,519.175
Kosten van de omzet 1,806.9931,541.0911,219.3891,223.3011,120.6771,189.022956.0051,003.195697.9851,147.047924.296713.129478.378897.845596.239394.788511.067892.901561.635559.467657.642596.8771,132.1731,278.6741,833.8211,354.3891,570.8262,075.366
Brutowinst 637.068629.93986.521764.252708.521909.986641.598649.301611.892634.276689.469564.228444.751297.752431.601690.743680.569222.325732.998756.879696.557827.921961.2421,284.6551,938.6791,327.1781,734.6552,443.809
Brutowinstmarge 0.2610.290.4470.3850.3870.4340.4020.3930.4670.3560.4270.4420.4820.2490.420.6360.5710.1990.5660.5750.5140.5810.4590.5010.5140.4950.5250.541
Onderzoek- en ontwikkelingskosten 070.937000000066.263000000000000000000
Algemene en administratieve kosten 0000000000000000000000000000
Verkoop- en marketingkosten 0000000000000000000000000000
Verkoop-, algemene en administratieve kosten 396.588424.946441.216355.521162.206349.498338.237293.794341.559339.848373.02285.283297.712139.72192.66197.625182.659210.343225.747211.122216.2080000000
Overige kosten 75.707-294.245-365.0683.55518.857-332.211-248.92758.39629.312-67.66523.65917.66831.233-34.58317.3659.31612.708-185.65570.15666.22751.52162.80447.1702,446.3681,573.7690.1310.029
Bedrijfskosten 396.588424.946284.098609.223564.173235.734248.584648.714703.693604.117751.006651.842650.177231.854770.878810.913784.047463.021,047.2191,083.011,132.5421,089.7881,059.9531,058.1342,446.3681,573.7691,735.7731,952.885
Bedrijfsresultaat 240.48204.984337.363238.284144.348342.041144.08758.983-91.80130.121-61.537-87.614-37.87864.844-321.912-110.854-321.912-381.665-314.221-259.904-244.065-163.547-51.543-603.142-507.689-246.591-0.987490.924
Bedrijfsresultaat ratio 0.0980.0940.1530.120.0790.1630.090.036-0.070.017-0.038-0.069-0.0410.054-0.313-0.102-0.27-0.342-0.243-0.197-0.18-0.115-0.025-0.235-0.135-0.092-00.109
Totaal overige inkomsten en kosten netto 40.72398.843-35.438-38.046-50.3317.266-76.803-92.212-49.092-41.561-44.152-81.265-67.811-99.296-125.334-133.314-125.334-6.92837.294-0.913-32.862-67.787-754.510-1,355.781-985.571-302.507-610.699
Inkomen voor belasting 281.203303.827301.925200.238107.751659.30767.284-33.229-140.893-11.44-105.689-168.879-282.979-34.452-447.246-244.168-226.623-388.593-276.927-260.817-384.464-231.334-806.053-603.142-1,863.47-1,168.198-303.494-119.775
Inkomen voor belasting ratio 0.1150.140.1370.1010.0590.3140.042-0.02-0.108-0.006-0.065-0.132-0.307-0.029-0.435-0.225-0.19-0.348-0.214-0.198-0.284-0.162-0.385-0.235-0.494-0.436-0.092-0.027
Belastingkosten -1.541-31.1917.6122.20118.85767.911-8.58520.71938.55357.4556.602-645.23232.943193.2520133.314125.334-0.88270.1560.91332.862-0.063-102.65-127.52140.002154.486-104.033-325.287
Nettowinst 293.506335.267294.313198.03794.048591.39675.869-53.948-150.134-65.864-138.632494.021-309.037-247.263-447.246-244.168-226.623-388.593-276.927-260.817-384.464-231.251-703.403-475.622-2,003.472-1,322.684-199.461205.512
Nettowinstmarge 0.120.1540.1330.10.0510.2820.047-0.033-0.115-0.037-0.0860.387-0.335-0.207-0.435-0.225-0.19-0.348-0.214-0.198-0.284-0.162-0.336-0.186-0.531-0.493-0.060.045
WPA (Winst Per Aandeel) 5.796.815.83.91.8514.491.86-1.32-3.68-1.61-3.412.1-7.57-6.06-10.96-5.98-5.55-9.52-6.78-2.93-4.32-2.6-7.91-5.58-28.44-18.77-2.832.92
Verwaterde WPA 5.796.815.83.91.8514.491.86-1.32-3.68-1.6-3.412.1-7.57-6.06-10.96-5.98-5.55-9.52-6.78-2.93-4.32-2.6-7.91-5.58-28.44-18.77-2.832.92
EBITDA 324.919289.184430.05316.693240.28414.162225.9236.625153.803299.312164.371130.72226.933268.118-31.984188.63205.708-69.67372.41957.131-70.764165.961284.842594.297-60.059203.714394.522917.934
EBITDA ratio 0.1330.1330.1950.1590.1310.1970.1410.1430.1170.1680.1020.1020.0290.224-0.0310.1740.173-0.0620.0560.043-0.0520.1160.1360.232-0.0160.0760.1190.203